Quick Takeaways
- This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 05 Jun 2024, 16:59.
Halley E. Gilbert - 03 Jun 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Role
- Director
- Signature
- /s/ Ron A. Metzger, Attorney-in-Fact
- Issuer symbol
- PCVX
- Transactions as of
- 03 Jun 2024
- Net transactions value
- -$1,231,230
- Form type
- 4
- Filing time
- 05 Jun 2024, 16:59:41 UTC
- Previous filing
- 17 May 2024
- Next filing
- 10 Jun 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 05 Jun 2024."
What Changed
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: -$1,231,230.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Common Stock | Options Exercise | $97,370 | +18,200 | +324% | $5.35* | 23,825 | 03 Jun 2024 | Direct | |
| transaction | PCVX | Common Stock | Sale | $1,328,600 | -18,200 | -76% | $73.00 | 5,625 | 03 Jun 2024 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Stock Option (Right to Buy) | Options Exercise | $0 | -18,200 | -37% | $0.000000 | 30,374 | 03 Jun 2024 | Common Stock | 18,200 | $5.35 | Direct | F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024. |
| F2 | Option is fully vested and exercisable. |
| F3 | Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings. |